BOHE Angel Fund
薄荷天使基金
BOHE Angel Fund (薄荷天使基金) is a China-based early-stage investment fund focused on healthcare and life sciences. Per FreeS Fund and Gaorong Capital deal reports, it has backed neurotech startup NeuroXess (co-investing in a RMB 42 million angel round in 2019) and structural-biology platform Shuimu BioSciences (co-investing in a tens-of-millions RMB angel round in 2020 alongside Gaorong Capital and Puhua Capital) . Elsewhere's corpus does not contain further detail on its AUM, vintage, or full portfolio.
AI-generated — may contain errors, please verify.
Coverage
Rongbao · May | Large-Memory Computing, Autonomous Driving and Other New Technologies Accelerate Adoption; Integration of Goods and Services Emerges as New Consumption Trend
Underlying technological innovation and new demographics are driving infinite possibilities.
Shuimu BioSciences Announces Angel Round to Build World-Class Next-Generation Drug Discovery Platform
Shuimu BioSciences has built Asia's first commercial protein structure analysis platform centered on 300kV top-tier cryo-EM, dedicated to using breakthrough technology to dramatically accelerate drug discovery and improve the druggability of difficult targets.
Brain Diseases in Its Crosshairs: NeuroXess Raises $4.2 Million in Angel Round | FreeS Fund Deal News
Brain research remains one of the great unsolved challenges in science.
